Apr 14, 2009 - Quinnova Pharmaceuticals, Inc. announced that it has received FDA clearance on the company's new product NEOSALUS CREAM, a line extension to the previously launched NEOSALUS FOAM, the first non-steroidal anti-inflammatory prescription topical foam product for the treatment of various types of dermatoses including atopic dermatitis and hand eczema.
The details can be read here.
No comments:
Post a Comment